Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Oct 12, 2024. (Total: 232444Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 5 (of 5 Records)

Query Trace: Efficiency and UGT1A1[original query]
UGT1A polymorphisms in a Swedish cohort and a human diversity panel, and the relation to bilirubin plasma levels in males and females.
European journal of clinical pharmacology 2006 Oct 62 (10): 829-37.
Mercke Odeberg J, Andrade J, Holmberg K, Hoglund P, Malmqvist U, Odeberg
Gilbert's syndrome: High frequency of the (TA)7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene for bilirubin UDP-glucuronosyltransferase 1 gene.
World journal of gastroenterology : WJG 2006 Apr 12 (14): 2269-75.
Farheen Shabana, Sengupta Sanghamitra, Santra Amal, Pal Suparna, Dhali Gopal Krishna, Chakravorty Meenakshi, Majumder Partha P, Chowdhury Abhij
The UDP-glucuronosyltransferase (UGT) 1A polymorphism c.2042C>G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a/5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-induced acute liver failure.
The Journal of pharmacology and experimental therapeutics 2013 May 345 (2): 297-307.
Court Michael H, Freytsis Marina, Wang Xueding, Peter Inga, Guillemette Chantal, Hazarika Suwagmani, Duan Su X, Greenblatt David J, Lee William M,
Metabolic activation and analgesic effect of flupirtine in healthy subjects, influence of the polymorphic NAT2, UGT1A1 and GSTP1.
British journal of clinical pharmacology 2015 Mar 79 (3): 501-13.
Siegmund Werner, Modess Christiane, Scheuch Eberhard, Methling Karen, Keiser Markus, Nassif Ali, Rosskopf Dieter, Bednarski Patrick J, Borlak Jürgen, Terhaag Ber
UGT1A1*6, UGT1A7*3 and UGT1A9*1b polymorphisms are predictive markers for severe toxicity in patients with metastatic gastrointestinal cancer treated with irinotecan-based regimens.
Oncology letters 2016 Nov 12 (5): 4231-4237.
Cui Chengxu, Shu Chang, Cao Dandan, Yang Yi, Liu Junbao, Shi Shuping, Shao Zhujun, Wang Nan, Yang Ting, Liang Hao, Zou Shanshan, Hu Songni
TOP